Symbiosis

Symbiosis is a global, client-focused, contract manufacturing organisation (CMO) offering GMP aseptic manufacture for clinical trials through to commercial supply. Utilising batch strategies closely aligned with the latest regulatory frameworks such as Annex 1, Symbiosis empowers drug developers to meet their project milestones through rapid access to fill-finish slots. Our purpose-built, FDA-inspected and MHRA-licensed manufacturing suites are designed to accommodate cytotoxic APIs and up to BSL-2. Working with liquid and lyophilised formulations, our expert in-house team has over ten years of experience taking a wide range of modalities from drug substance to QP release e.g. mAbs, vaccines, small molecules, ADCs, ATMPs, etc. As trusted partners, Symbiosis are dedicated to supporting our clients facilitate safe, life-saving injectable drug therapies, without delay.